Trial Profile
A Phase I study of rontalizumab
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Mar 2017
Price :
$35
*
At a glance
- Drugs Rontalizumab (Primary)
- Indications Systemic lupus erythematosus
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Chugai Pharmaceutical
- 07 Jun 2016 New trial record